Flowermate: Go Pro or Go Mini?

By Barabara M.

When deciding on a new vaporizer it can be extremely difficult to choose which one to buy. Today there are just so many available and deciding on a vaporizer that will perform as well as you want it to can be a strenuous enterprise. That’s why today we’re going to show you two vaporizers from a company that delivers a quality vaporizer each and every time.

Flowermate Technology is a company devoted to bringing the very best in vaping technology to their customers at affordable prices. Each one of their units is designed to be practical and create an unparalleled experience to other units in the industry. The Flowermate V5 Pro and the Flowermate V5 Mini are just of their units that live up to this bold mission statement.

Design

The V5 Pro

The Flowermate V5 Pro is a wonderful choice in a vaporizer for absolutely anyone. Flowermate designed it with an eye towards simplicity and that’s just what they achieved.  It’s easy to use and perfectly suitable for a first timer and would be no problem for someone with previous experience. There are just three buttons on the body of the vaporizer. One main button to powers the unit on or off and two other buttons adjust the temperature incrementally.

Incremental Heating

Controlling heat settings is of the utmost importance for any vaporizer. And by using the two smaller buttons on the Flowermate V5 Pro you can shift the temperature in tiny 1-degree increments. This level of control is what sets this vaporizer beyond others on the market. Plus, there is almost no chance of combustion, which is always a good thing.

The materials Flowermate utilize in their designs are also top of the range. Every vaporizer is made from high-quality materials. The heating chamber is entirely constructed from ceramic your material will always be evenly heated. The mouthpiece is made from Pyrex, a quality glass

Kentucky Governor Signs Resolution Urging Feds to Legalize Hemp

A resolution urging the federal government to legalize hemp has been signed into law by Kentucky Governor Matt Bevin.

Governor Bevin’s signing of Kentucky House Concurrent Resolution 35 comes less than two weeks after it was approved, unanimously (36 to 0), by the state’s Senate. In February it was passed by the House of Representatives in an overwhelming 93 to 2 vote.

The resolution states that the “General Assembly of the Commonwealth of Kentucky urges the United States Congress to take action by enacting legislation that:

(1) Encourages large-scale commercial cultivation of hemp by removing it from the list of controlled substances under the federal Controlled Substances Act;

(2) Prevents the federal Drug Enforcement Administration (DEA) from sending DEA agents onto farms and other sites where hemp is being grown, stored, and processed;

(3) Creates legal protections for depository institutions that provide financial services to legitimate hemp businesses; and

(4) Instructs the federal Food and Drug Administration to accelerate clinical trials and other research on the health effects of cannabidiol (CBD) and other cannabinoids found in hemp.

The full resolution can be found by clicking here.

The post Kentucky Governor Signs Resolution Urging Feds to Legalize Hemp appeared first on TheJointBlog.

from https://thejointblog.com/kentucky-governor-signs-resolution-urging-feds-to-legalize-hemp/…

Albuquerque City Council Gives Approval to Marijuana Decriminalization Ordinance

The Albuquerque, New Mexico City Council has passed an ordinance that would decriminalize the possession of personal amounts of marijuana.

The ordinance, which was approved by the council in a close 5 to 4 vote,  would make the possession of up to an ounce (28 grams) of marijuana a simple $25 ticket. Currently possessing even a gram of marijuana can result in a misdemeanor and being put in jail for up to 15 days.

Councilmember Pat Davis, who filed the measure with Councilmember Isaac Benton, compared the ticket that would be issued for marijuana possession to a traffic ticket. He says it beats “having to check a box for the rest of your life”, referring to those filing applications (either for work, school, etc.) and being asked if they’ve ever been convicted of a drug-related crime. “At the end of the day, our police officers have more important things to do”, says Davis.

Before the proposal can become law, if must either be signed by Mayor  Tim Keller (D), or be allowed by him to become law without his signature. A similar measure was vetoed in 2015, but at that point Keller wasn’t mayor; Richard Berry (R) was.

Albuquerque is by far the most populated city in New Mexico with roughly 560,000 residents, roughly a fourth of all residents in New Mexico (which has a population of slightly over 2 million).

The post Albuquerque City Council Gives Approval to Marijuana Decriminalization Ordinance appeared first on TheJointBlog.

from https://thejointblog.com/albuquerque-city-council-gives-approval-to-marijuana-decriminalization-ordinance/…

Louisiana Committee Votes to Add Autism Spectrum Disorder to State’s Medical Marijuana Program

A Louisiana House committee has voted in favor of a bill to add autism spectrum disorder to the state’s list of qualifying medical marijuana conditions.

The House Health and Welfare Committee voted 9 to 4 last week to pass House Bill 627, sending it towards a vote by the full House of Representatives. The bill would expand the state’s medical marijuana program, approved in 2017, by adding autism spectrum disorders to the list of qualifying conditions.

John Vanchierre, M.D., who heads up the Louisiana chapter of the American Academy of Pediatrics, argued  in opposition to the measure, saying that there isn’t enough studies proving that marijuana can help those with autism.

“Allowing medical marijuana to be used, without FDA standards, is not appropriate”, said Vanchierre. “This is a safety issue”.

Representative Larry Bagley responded by saying that “I’ve always voted along the lines going with doctors who say it won’t work. I’m getting a little weary of waiting for these studies.”

Cardiologist Dr James Smith spoke in support of the bill; “Cannabis is a safe medicine. 900 people died last year from acetominophine. None from cannabis”.

 House Bill 627 now moves towards a full House vote. If passed by the House, it will be sent to the Senate, where approval will send it to Governor John Bel Edwards for final consideration.

 

The post Louisiana Committee Votes to Add Autism Spectrum Disorder to State’s Medical Marijuana Program appeared first on TheJointBlog.

from https://thejointblog.com/louisiana-committee-votes-to-add-autism-spectrum-disorder-to-states-medical-marijuana-program/…

Switzerland Lawmakers Unanimously Approve Marijuana Legalization Pilot Program

Switzerland’s lower house has unanimously approved a bill that would allow marijuana to be sold legally as part of a pilot program.

The program is designed to allow officials to research the impacts of allowing marijuana to be legally sold through licensed outlets. It would allow 1,000 people to purchase marijuana from government-approved and licensed establishments, which will likely be modeled after Amsterdam-style coffee shops.

“We need to research this issue so we have scientifically-valid data to base our decisions on when discussing the future of cannabis laws”, says MP Roberto Zanetti (Social Democrat). “This law would give us just that”.

Having already passed the lower house, the measure now heads to the National Council, who will have the final say over whether it becomes law.

Although marijuana is illegal in Switzerland, the possession of up to 10 grams has been decriminalized since 2013. In 2001 lawmakers passed a bill to legalize marijuana, though it was rejected by the National Council due to pressure from the United Nations.

The post Switzerland Lawmakers Unanimously Approve Marijuana Legalization Pilot Program appeared first on TheJointBlog.

from https://thejointblog.com/switzerland-lawmakers-unanimously-approve-marijuana-legalization-pilot-program/…

CBD vs. CBN: What’s The Actual Difference

CBD vs CBN

As experts in all things marijuana, we get asked a lot of cannabis questions. Those questions range from grow tips to strain suggestions to consumption options. Lately, we’ve been getting some questions about CBD vs. CBN.

People are pretty curious about these cannabis components. And for good reason: CBD and CBN are becoming essential medical treatments for a variety of disorders.

We’ll explore those disorders later. But first, we’ll answer a few important questions:

  • What are CBD and CBN?
  • How do they work?
  • How are CBD and CBN produced in the cannabis plant?
  • Will they get you high?

Along the way, we’ll also investigate the benefits and side effects of both CBD and CBN. Let’s start from the top.

What Are CBD & CBN?

CBD is the abbreviation for the word cannabidiol. CBN is the abbreviation for the word cannabinol. Both CBD and CBN are chemical compounds known as cannabinoids. Scientists have isolated 113 different cannabinoids, including:

  • CBG
  • CBC
  • CBT
  • THCA
  • THCV
  • CBL
  • CBE

The most famous (infamous?) cannabinoid is THC (short for tetrahydrocannabinol) thanks to its powerful psychedelic effects. Even if you’ve never experienced a marijuana high first-hand, you’re probably at least familiar with the effects of THC thanks to marijuana’s long-standing presence in movies and TV.

CBD and CBN are different than THC for a number of different reasons, which we’ll discuss in a later section. First, though, it’s vital that you understand how CBD and CBN work in your body.

How Do CBD & CBN Work?

When you smoke, dab, eat, vape, or in any other way consume a cannabis product, you introduce cannabinoids like CBD and CBN into your bloodstream. Your blood circulates the cannabinoids throughout your body and into your brain.

Once there, the cannabinoids dock with (and activate) special neurons that then produce a wide range of effects—both elsewhere in your brain and throughout your body.

Think of …

April Cannabis Events: The 420 Special

Apr. 6-7, 13-14, 20-21, 27-28: Reefer Madness: The Musical, The Bug Theatre, Denver, CO 

Apr. 7: Hash Bash, University of Michigan, Ann Arbor, MI

April 7-8: Reno Cannabis Convention, Whitney Peak Hotel, Reno, NV

Apr. 7-8: Grassroots Expo for the Cannabis Curious, UBC Robson Square, Vancouver, BC

Apr. 11-13: International Cannabis Business Conference featuring Henry Rollins and DJ Muggs, Maritim Hotel, Berlin, Germany

Apr. 19: 420 Eve on the Rocks featuring 311, Method Man & Redman, Collie Buddz, Long Beach Dub Allstars, PROF and Chali2na; Red Rocks Amphitheatre, Morrison, CO

Apr. 19-22: Palm Springs Cannabis Film Festival & Summit, Camelot Theatres, Palm Springs, CA

Apr. 20: Mile High 420 Festival featuring Lil Wayne, Lil Jon, the Wailers, Inner Circle and Whitewater Ramble; Civic Center Park, Denver, CO

Apr. 20: Hippie Hill Festival, Golden Gate Park, San Francisco, CA

Apr. 20-22: Sweetwater 420 Fest featuring the String Cheese Incident, Umphrey’s McGhee, Tedeschi Trucks Band, Sturgill Simpson and more; Centennial Park, Atlanta, GA

Apr. 20-22: High Cannabis Cup SoCal, NOS Event Center, San Bernardino, CA

Apr. 20-22:

Study: Cannabis Could Represent an Effective and Well-Tolerated Treatment for Epileptic Seizures

According to a new study published by Epilepsia Open, “cannabis could actually represent an effective, well-tolerated antiepileptic drug”.

“Cannabidivarin (CBDV) and cannabidiol (CBD) have recently emerged among cannabinoids for their potential antiepileptic properties, as shown in several animal models”, states the study’s abstract. “We report the case of a patient affected by symptomatic partial epilepsy who used cannabis as self-medication after the failure of countless pharmacological/surgical treatments.”

Clinical and video electroencephalogram (EEG) evaluations were periodically performed, and the serum levels of CBDV, CBD, and Δ9-tetrahydrocannabinol were repeatedly measured. After cannabis administration, “a dramatic clinical improvement, in terms of both decrease in seizure frequency and recovery of cognitive functions, was observed, which might parallel high CBDV plasma concentrations.”

To widen the spectrum of CBDV possible mechanisms of action, “electrophysiological methods were applied to investigate whether it could exert some effects on γ-aminobutyric acid (GABA)A receptors.”

According to the study; “Our experiments showed that, in human hippocampal tissues of four patients affected by drug-resistant temporal lobe epilepsy (TLE) transplanted in Xenopus oocytes, there is decrease of current rundown (i.e., reduction of use-dependent GABAA current) after prolonged exposure to CBDV. This result has been confirmed using a single case of Rasmussen encephalitis (RE).”

They conclude by stating that; “Our patient’s electroclinical improvement supports the hypothesis that cannabis could actually represent an effective, well-tolerated antiepileptic drug. Moreover, the experimental data suggest that CBDV may greatly contribute to cannabis anticonvulsant effect through its possible GABAergic action.”

For the full study, click here.

The post Study: Cannabis Could Represent an Effective and Well-Tolerated Treatment for Epileptic Seizures appeared first on TheJointBlog.

from https://thejointblog.com/study-cannabis-could-represent-an-effective-and-well-tolerated-treatment-for-epileptic-seizures/…

Senate Leader McConnell to Introduce Hemp Legalization Bill

Left to right: Kentucky’s pro-hemp senators, Rand Paul (left) and Mitch McConnell.

Kentucky farmers have long been at the forefront of hemp cultivation in America. With records of it being planted there dating back to 1775, it’s fitting that nearly 250 years later a senator from Kentucky would spearhead efforts to separate hemp—at least agriculturally—from its psychoactive cousin.

On March 26, Senate Majority Leader Mitch McConnell (R-Ky.) announced that he plans to introduce the Hemp Farming Act of 2018. If passed by Congress, it would finally legalize hemp as an agricultural commodity and remove it from the Controlled Substances Act.

“Hemp has played a foundational role in Kentucky’s agricultural heritage,” McConnell explained at the state Department of Agriculture in Frankfort, where he was joined by Commissioner of Agriculture Ryan Quarles. “I believe it can be an important part of our future. We’re ready to take the next step and build upon the successes we’ve seen with Kentucky’s hemp pilot program.”

Hemp farming in Kentucky has experienced a resurgence since the passage of the Agricultural Act of 2014 (a.k.a. the Farm Bill), which defined industrial hemp as distinct from marijuana, and authorized colleges, universities and the Agriculture Department to grow it for research under pilot programs. The amount of hemp planted in the Bluegrass State has increased from 33 acres to more than 3,200 since the pilot program was launched in 2015. As of February, the Agriculture Department had 248 growers and 35 processors participating. Quarles believes hemp’s long-term prospects in Kentucky are promising, as the state has a network of tobacco processors that can turn raw hemp into products such as plastics, textiles and construction materials.

Study: Cannabis has Theurputic Potential in the Treatment of Alzheimer’s Disease

Cannabis may provide a potential treatment option for those with Alzheimer’s disease, states a new study published by the journal Neurochemical Research.

“Here we demonstrate for the first time that cannabidiol (CBD) acts to protect synaptic plasticity in an in vitro model of Alzheimer’s disease (AD)”, begins the study’s abstract. “The non-psycho active component of Cannabis sativa, CBD has previously been shown to protect against the neurotoxic effects of beta amyloid peptide (Aβ) in cell culture and cognitive behavioural models of neurodegeneration. Hippocampal long-term potentiation (LTP) is an activity dependent increase in synaptic efficacy often used to study cellular mechanisms related to memory.”

Here, researchers “show that acute application of soluble oligomeric beta amyloid peptide (Aβ1-42) associated with AD, attenuates LTP in the CA1 region of hippocampal slices from C57Bl/6 mice. Application of CBD alone did not alter LTP, however pre-treatment of slices with CBD rescued the Aβ1-42 mediated deficit in LTP.” The study found “that the neuroprotective effects of CBD were not reversed by WAY100635, ZM241385 or AM251, demonstrating a lack of involvement of 5HT1A, adenosine (A2A) or Cannabinoid type 1 (CB1) receptors respectively. However in the presence of the PPARγ antagonist GW9662 the neuroprotective effect of CBD was prevented.”

Researchers conclude; “Our data suggests that this major component of Cannabis sativa, which lacks psychoactivity may have therapeutic potential for the treatment of AD.”

The full study can be found by clicking here.

This new research helps to validate a plethora of past studies which found that cannabinoids may treat, and may even prevent, Alzheimer’s disease. You can find information on some of these  past studies by clicking  here.

The post Study: Cannabis has Theurputic Potential in the Treatment of Alzheimer’s Disease appeared first on TheJointBlog.

from https://thejointblog.com/study-cannabis-has-theurputic-potential-in-the-treatment-of-alzheimers-disease/…

Book Review: The Hunt for Timothy Leary

Ever see one of those action-adventure flicks where the writers try to stuff everything in, including the kitchen sink? You know, the big-budget buddy movie with exotic locales, international intrigue, improbable exploits, white-knuckle action sequences, witty dialogue, rapid-fire editing and lots of celebrity cameos? And then they blow your mind by insisting it’s based on a true story?

Authors Steven L. Davis and Bill Minutaglio

Bill Minutaglio and Steven L. Davis’ The Most Dangerous Man in America: Timothy Leary, Richard Nixon and the Hunt for the Fugitive King of LSD (their previous book, Dallas 1963, received a PEN Center literary award for research nonfiction in 2014) doesn’t read like a nonfiction book as much as it feels like watching the film version of a book. It’s set in the circa-1970 era of antiwar protests, riots and terrorist attacks.

American society was fracturing as the unpopular war in Vietnam fueled dissent. The Weather Underground, the Black Panther Party and other revolutionary groups viewed violence as “by any means necessary.” In the middle of this commotion was a mild-mannered former Harvard professor turned psychedelic evangelist, Dr. Timothy Leary.

A consummate showman, Leary spent years promoting the use of psychedelics, in particular LSD, and free love to the outrage of establishment America. First at an estate in Millbrook in upstate New York, then in Laguna Beach, Calif., he offered a psychedelic-driven message with catchphrases like “turn on, tune in, drop out” and “question authority.” To hippies, he was a sybarite philosopher king, a celebrity messiah of all things groovy. To President Richard Nixon and his supposed “Silent Majority,” Leary symbolized all they couldn’t stand in the cultural and political upheavals of the time.

New Jersey Adds Five New Medical Marijuana Conditions, Reduces Patient Fee

New Jersey Governor Phil Murphy announced today that the state is expanding their medical marijuana program to include five new conditions that qualify an individual to legally use the medicine.

Governor Murphy announced the expansion the same day as a governor-appointed task force recommended he do so. The conditions being added are migraines, anxiety, chronic pain related to musculoskeletal disorders, chronic visceral pain, and Tourette’s syndrome. Governor Murphy also announced that the fee to become a medical marijuana patient is being reduced from $200, to $100, or $20 for veterans and seniors.

“We are changing the restrictive culture of our medical marijuana program to make it more patient-friendly,” says Murphy. “We are adding five new categories of medical conditions, reducing patient and caregiver fees, and recommending changes in law so patients will be able to obtain the amount of product that they need. Some of these changes will take time, but we are committed to getting it done for all New Jersey residents who can be helped by access to medical marijuana.”

Other changes include removing the limit of one-caregiver per patient, and allowing physicians to recommend the medicine without being required to appear on a public registry.

Governor Murphy, elected last year, has vowed to take things even further, and is working to legalize marijuana in New Jersey for all uses, given the consumer is at least 21.

The post New Jersey Adds Five New Medical Marijuana Conditions, Reduces Patient Fee appeared first on TheJointBlog.

from https://thejointblog.com/new-jersey-adds-five-new-medical-marijuana-conditions-reduces-patient-fee/…

NFL Hall of Famer Speaks Out at Cannabis Opportunity Summit

MCBA board chair Khavan Khalatbari and NFL Hall of Famer Terrell Davis at the Cannabis Opportunity Summit in Denver on March 23. (Photo by Wally Wallace)

Former NFL running back and Denver sports legend Terrell Davis showed off the Hall of Fame ring he received in 2017 to a crowd of 500 attendees at the Minority Cannabis Business Association’s Cannabis Opportunity Summit on March 23 at the University of Denver.

The Broncos’ all-time leading rusher doesn’t use marijuana for pain or any other lingering condition. But he remembers how the arrests of mostly young black men for marijuana damaged their lives when he grew up in San Diego. Davis thinks it’s time to change that cycle, and sees the development of minority-owned cannabis businesses as one way to accomplish that.

“As minorities, we’re always underdogs,” he pointed out. “We’ve always been labeled ‘can’t do it.’ That’s all we heard growing up. I’ve heard that since I was seven years old. That’s what you guys are now. You’re the underdogs. Embrace it. Take chances. It’s a risky business, and you take the risks. I like that.”

The summit was the brainchild of Kayvan Khalatbari, an Iranian-American entrepreneur who cofounded Denver Relief, Colorado’s second-oldest medical-marijuana dispensary. He’s also chair of the MCBA’s board and is running for mayor of Denver in the 2019 election. After 13 years in the cannabis industry, Khalatbari’s concerned about white males dominating it. “In new states where you see a very limited number of licenses and such a high barrier of entry, marginalized people can’t play, no matter what color they are,” he told Freedom Leaf.

Study: Cannabidiol May Help Prevent Relapses in Those Addicted to Alcohol and Drugs

The findings of a study published last week by the journal Neuropsychopharmacology “provide proof of principle supporting potential of CBD [cannabidiol] in relapse prevention”.

“Cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativa, has received attention for therapeutic potential in treating neurologic and psychiatric disorders”, states the study’s abstract. “Recently, CBD has also been explored for potential in treating drug addiction.” The study notes that substance use disorders “are chronically relapsing conditions and relapse risk persists for multiple reasons including craving induced by drug contexts, susceptibility to stress, elevated anxiety, and impaired impulse control.” Here, researchers “evaluated the “anti-relapse” potential of a transdermal CBD preparation in animal models of drug seeking, anxiety and impulsivity.”

For the study, rats with alcohol or cocaine self-administration histories “received transdermal CBD at 24 h intervals for 7 days and were tested for context and stress-induced reinstatement, as well as experimental anxiety on the elevated plus maze.” Effects on impulsive behavior were established using “a delay-discounting task following recovery from a 7-day dependence-inducing alcohol intoxication regimen.”

Researchers found that; “CBD attenuated context-induced and stress-induced drug seeking without tolerance, sedative effects, or interference with normal motivated behavior. Following treatment termination, reinstatement remained attenuated up to ≈5 months although plasma and brain CBD levels remained detectable only for 3 days.” CBD also “reduced experimental anxiety and prevented the development of high impulsivity in rats with an alcohol dependence history.”

The study concludes by stating that; “The results provide proof of principle supporting potential of CBD in relapse prevention along two dimensions CBD: beneficial actions across several vulnerability states, and long-lasting effects with only brief treatment. The findings also inform the ongoing medical marijuana debate concerning medical benefits of non-psychoactive cannabinoids and their promise for development and use as therapeutics.”

The study can be found by clicking here (though we note that the full study is behind a paywall).

The post Study: Cannabidiol May Help Prevent Relapses

Study: Cannabinoids May Alleviate Dystonia and Other Huntington’s Disease Symptoms

Those with Hungtington’s disease may be able to treat some of their symptoms, including dystonia, with cannabinoids, according to a new study.

“Treatment options for dystonia are limited”, states the study’s abstract. “Cannabinoids have been described as a potential treatment for patients with dystonia of a different origin. Here, we present early onset HD [Huntington’s disease] patients with a marked improvement of motor symptoms mainly due to alleviation of dystonia due to treatment with cannabinoids.” In addition, “we review the current literature concerning the use of cannabinoids in HD. Dystonia is described by the Mayo Clinic as “Involuntary muscle contractions that cause repetitive or twisting movements.”

According to researchers, “The Unified Huntington’s Disease Rating Scale (UHDRS) motor score, including a chorea and dystonia subscore, was conducted before and after the start of cannabinoids in seven patients without any other changes in medication. The UHDRS motor score and the dystonia subscore (±SD) improved from 70.9 (25.5) to 60.6 (26.9) with a mean change of 10.3 [95% CI 6.0-14.6] and from 12.3 (4.0) to 8.0 (3.6) with a mean change of 4.3 [95% CI 2.3-6.3], respectively (both p = 0.018).”

They conclude; “Improvement of motor symptoms, mainly dystonia, led to several relevant improvements from a global clinical perspective such as improvement of care, gait and fine motor skills and weight gain. Moreover, we observed changes in behavior with less irritability and apathy, as well as less hypersalivation in some cases.”

The full study can be found by clicking here.

The post Study: Cannabinoids May Alleviate Dystonia and Other Huntington’s Disease Symptoms appeared first on TheJointBlog.

from https://thejointblog.com/study-cannabinoids-may-alleviate-dystonia-and-other-huntingtons-disease-symptoms/…

Study: Cannabinoids May Help Treat Gut Inflammation

There’s “abundant preclinical literature demonstrating the anti-inflammatory effects of cannabinoid drugs in inflammation of the gut”, according to a new study published by the journal Inflammatory Bowel Disease.

For the study, researchers “systematically reviewed publications on the benefit of drugs targeting the endo-cannabinoid system in intestinal inflammation.” They “collated studies examining outcomes for meta-analysis from EMBASE, MEDLINE and Pubmed until March 2017. Quality was assessed according to mSTAIR and SRYCLE score.”

For the study, “51 publications examining the effect of cannabinoid compounds on murine colitis and 2 clinical studies were identified. Twenty-four compounds were assessed across 71 endpoints. Cannabidiol, a phytocannabinoid, was the most investigated drug.”

Researchers found that cannabinoids significantly reduced the disease activity index for colitis. They found “no evidence of reporting bias” among the studies they examined, and report that “No significant difference was found between the prophylactic and therapeutic use of cannabinoid drugs.”

The study concludes by stating; “There is abundant preclinical literature demonstrating the anti-inflammatory effects of cannabinoid drugs in inflammation of the gut. Larger randomised controlled-trials are warranted.”

The full study, conducted by researchers at the University of Nottingham in the United Kingsom, can be found by clicking here.

The post Study: Cannabinoids May Help Treat Gut Inflammation appeared first on TheJointBlog.

from https://thejointblog.com/cannabinoids-gut-inflammation/…

Canada Senate Votes to Legalize Marijuana for Those 18+

Canada’s Senate has voted to pass a marijuana legalization bill through its second reading.

The Senate passed Bill C-45 yesterday in a 44 to 29 vote. The measure, which would legalize marijuana for everyone 18 and older, passed the House of Commons  in November by a vote of 200 to 82. The bill will now go through a third reading in the Senate. If passed, as expected, it will be sent to the Governor General for Royal Assent (final approval).

If the measure does become law as many anticipate and as Prime Minister Justin Trudea has promised, the possession and personal cultivation of marijuana will become legal for those 21 and older. The measure would establish a system of licensed brick-and-mortar cannabis retail outlets, while also allowing cannabis to be sold online.

According to a report released last year by the C.D. Howe Institute, Canada is set to garner approximately $675 million ($500 million US) annually in tax revenue from legal marijuana sales.

The post Canada Senate Votes to Legalize Marijuana for Those 18+ appeared first on TheJointBlog.

from https://thejointblog.com/canada-senate-votes-to-legalize-marijuana-for-those-18/…

Rohrabacher-Blumenauer Amendment Safe Until September

Rohrabacher

Reps. Rohrabacher (right) and Blumenauer in 2014. (Photo by Tom Williams/CQ Roll Call)

ORIGINALLY POSTED JAN. 17, UPDATED MAR. 22: With Attorney General Jeff Sessions rescinding the Cole Memo on Jan. 4, the Rohrabacher-Blumenauer amendment (RBA) has been the only federal law standing in the way of a potential crackdown on medical marijuana. On Mar. 21, it was extended for another for another six months.

First passed in 2014, Rohrabacher-Blumenauer (then known as Rohrabacher-Farr) is an amendment to the annual appropriations bill that prohibits the Department of Justice from using federal funds to crack down on medical marijuana programs in the 29 states where it’s legal. This is the RBA’s third extension since December.

Rep. Blumenauer (D-Ore.) took the extension in stride, stating:

“While I’m glad that our medical marijuana protections are included, there is nothing to celebrate since Congress only maintained the status quo. These protections have been law since 2014. This matter should be settled once and fort all.”

Several ongoing cases rest on RBA protections. Last August, a federal judge in San Francisco cited the RBA in a ruling …

Hawaii Committee Passes Resolution Urging NFL to Allow Players to Use Medical CBD

A Hawaii House Committee has given approval to a resolution urging the National Football League (NFL) to allow players to use CBD (cannabidiol) for medical purposes.

Hawaii’s House Health and Human Services Committee unanimously approved House Resolution 40 on Wednesday, sending it towards a vote by the full House of Representatives. The resolution states; “BE IT RESOLVED by the Senate of the Twenty-ninth Legislature of the State of Hawaii, Regular Session of 2018, the House of Representatives concurring, that the National Football League is urged to allow injured National Football League players to use cannabidiol in pill or liquid form, in lieu of opioids, to address the pain from work-related injuries”.

The resolution also states; “BE IT FURTHER RESOLVED that certified copies of this Concurrent Resolution be transmitted to the Commissioner of the National Football League and the respective General Managers of each of the teams that compose the National Football League.”

A companion bill, Senate Concurrent Resolution 34, was recently assigned to the Senate Labor Committee.

The post Hawaii Committee Passes Resolution Urging NFL to Allow Players to Use Medical CBD appeared first on TheJointBlog.

from https://thejointblog.com/hawaii-committee-passes-resolution-urging-nfl-to-allow-players-to-use-medical-cbd/…

Study: Marijuana Use Associated With Reduced Mortality Following Orthopedic Surgery

Marijuana use was associated with decreased mortality in patients undergoing a variety of surgical procedures, according to a study of over 9 million patients, published in the journal Substance Abuse.

“The association between marijuana use and surgical procedures is a matter of increasing societal relevance that has not been well studied in the literature”, states the study’s abstract. “The primary aim of this study is to evaluate the relationship between marijuana use and in-hospital mortality, as well as to assess associated comorbidities in patients undergoing commonly billed orthopedic surgeries.”

To do so, the National Inpatient Sample (NIS) database from 2010 to 2014 was used to determine the odds ratios for the associations between marijuana use and in-hospital mortality, heart failure (HF), stroke, and cardiac disease (CD) in patients undergoing five common orthopedic procedures: hip (THA), knee (TKA), and shoulder arthroplasty (TSA), spinal fusion, and traumatic femur fracture fixation.

“Of 9,561,963 patients who underwent one of the five selected procedures in the four-year period, 26,416 (0.28%) were identified with a diagnosis of marijuana use disorder”, states researchers. “In hip and knee arthroplasty patients, marijuana use was associated with decreased odds of mortality compared to no marijuana use.” Traumatic femur fixation patients had the highest prevalence of marijuana use (0.70%), which was associated with “decreased odds of mortality, HF, and CD.” For spinal fusions, “Marijuana use in patients undergoing shoulder arthroplasty “was associated with decreased odds of mortality”.

Researchers conclude by stating that; “In this study, marijuana use was associated with decreased mortality in patients undergoing THA, TKA, TSA and traumatic femur fixation, although the significance of these findings remains unclear. More research is needed to provide insight into these associations in a growing surgical population.”

The full study can be found by clicking  here.

The post Study: Marijuana Use Associated With Reduced Mortality Following Orthopedic Surgery appeared first on TheJointBlog.

from https://thejointblog.com/study-marijuana-use-associated-with-reduced-mortality-following-orthopedic-surgery/…

Cannabis at SXSW: Pot Panels, Movies and More

Back when I was an Austin resident from 1994-1996, SXSW celebrated the weirdness of Austin. Local bands played up and down 6th St., hoping for national recognition from industry types who descended on the Texas capitol every March. Twenty-four years later, it’s grown into a 10-day celebration of film, music, technology and progressive thought.

Texas is flirting with medical cannabis and attracting some young, vibrant political figures that want to bring legalization to the Lone Star State. SXSW is the perfect vehicle for furthering this goal. The thousands of attendees are smart and not afraid of taking risks (although most of their risks focus on coding and instrumental harmonies). At the same time, the world of sensory enhancement is one they generally embrace.

There were several chances to engage in cannabis discussions and education at SXSW 2018. I participated in a panel on professional sports with Jim McAlpine, founder of the 420 Games, and Eben Britton, a former NFL player who formed Athletes for Care, We all advocated for the use of cannabis as a substitute for the prescription drugs that athletes are fed in the name of winning.

Other canna-panels featured Ardent Cannabis’ Shanel Lindsay, Bloomberg reporter Jennifer Kaplan, futurist Faith Popcorn and Morgan Paxhia from Poseidon Asset Management. There was a “clean cannabis” meet-up, a talk about marijuana as the next superfood and the Grasslands fundraiser for Rep. Beto O’Rourke, who’s running against Sen. Ted Cruz for his Senate seat, hosted by Ricardo Baca. The world premiere of Weed the People—directed by Abby Epstein, produced by Ricki Lake and featuring this cannabis blogger—was also a highlight.

Voters in Illinois’ Most Populated County Approve Marijuana Legalization Referendum

Voters in Cook County, which includes Chicago, have overwhelmingly approved a nonbinding referendum calling for the legalization of marijuana.

With over 63% voting in favor, Cook County voters approved the resolution asking: “Shall the State of Illinois legalize the cultivation, manufacture, distribution, testing, and sale of marijuana and marijuana products for recreational use by adults 21 and older subject to state regulation, taxation and local ordinance?”

The resolution, which was supported by Cook County Board President Toni Preckwinkle, isn’t legally binding, meaning it will have no effect on the county’s marijuana laws. However, it does give state lawmakers a good indication of how strong support is for legalization among a very large chunk of voters.

Cook County is  by far the  most populated county in Illinois, with approximately 5.2 million residents. This is over five times the population of the state’s second largest county, DuPage County (around 930,000).

The post Voters in Illinois’ Most Populated County Approve Marijuana Legalization Referendum appeared first on TheJointBlog.

from https://thejointblog.com/voters-in-illinois-most-populated-county-approve-marijuana-legalization-referendum/…

CBD Patch: The Ultimate Guide To CBD Transdermal Patches

CBD Patch

We here at Honest Marijuana love it when cannabis and creativity join forces. It’s the answer to our every “shipping” dream (cannativity? creatabis?) and has produced some truly unique forms of marijuana, like Thai sticks, moon rock, and purple weed. But nothing even comes close to the joy we feel when we think about CBD patches.

Though the CBD patch and the THC patch have only been around for a few years, transdermal patches have existed for almost 40 years. Way back in 1979 when dinosaurs still roamed the earth and kids had to walk to school uphill both ways, the FDA approved the first transdermal patch (scopolamine for motion sickness).

Other patches followed, but the most famous transdermal patch is the nicotine patch, which was introduced in 1991 to help tobacco users kick the smoking habit.

With the legalization of medical and recreational cannabis in the early part of the 21st century, the next logical step was the CBD patch. Now that it has finally arrived, we’re sure it’ll take the crown as the most famous transdermal patch of them all.

But what exactly are CBD patches, and how do they work? The experts at Honest Marijuana will answer that question and reveal everything you need to know about the newest and coolest way to get the CBD you need.

First, though, let’s talk about the ingredient that makes a CBD patch a CBD patch.

What Is CBD?

CBD molecule

CBD (cannabidiol) is one of many chemical compounds within the cannabis plant. Scientists have given these compounds the name cannabinoids. THC is perhaps the most well-known cannabinoid. Others include:

  • CBG (cannabigerol)
  • CBL (cannabicyclol)
  • CBN (cannabinol)
  • CBT (cannabicitran)

And those are just the tip of the cannabinoid iceberg. Scientists have isolated 113 different cannabinoids. Think of these as building blocks that make up the entire chemical composition of the cannabis plant. Pretty cool, huh?

What Is A CBD

From Yippie to Yuppie: ’60s Activist Jerry Rubin

The Youth International Party (Yippies) went beyond the simple peace-and-love mentality of the hippies of the ’60s and ’70s. They were politicized hippies and psychedelicized activists who took their protests against the Vietnam war and America’s repressive status quo to the streets, often theatrically.

Jerry Rubin was one of them, and along with rabble-rousing peers like Abbie Hoffman, Paul Krassner and Stew Albert, they stirred up dissent on a national scale. While Hoffman was the subject of Steal This Movie in 2000, little has been written about his Yippie running partner until now, thanks to Pat Thomas’ exhaustive Did It! (Fantagraphics Books).

“Jerry Rubin and Abbie Hoffman manipulated the media with the ease of carnival barkers at a county fair.”

Designed as a scrapbook-style homage to the structure of Rubin’s 1970 classic Do It! and Hoffman’s Steal This Book, Did It! balances the scales of history, giving Rubin his due as a flawed but vital member of the counterculture. Among his Yippie highlights were throwing dollar bills to a bevy of greedy brokers at the New York Stock Exchange, nominating a pig for President, encircling and pretending to levitate the Pentagon and turning the incredibly undemocratic proceedings of the infamous Chicago 8 trial in 1969-70, in which he was one of the defendants, into five months of political theater and chaos. Back then, Rubin and Hoffman manipulated the media with the ease of carnival barkers at a county fair.